These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30874834)

  • 1. Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome.
    Offiah I; Dilloughery E; McMahon SB; O'Reilly BA
    Int Urogynecol J; 2019 Aug; 30(8):1293-1301. PubMed ID: 30874834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond a Simple Anesthetic Effect: Lidocaine in the Diagnosis and Treatment of Interstitial Cystitis/bladder Pain Syndrome.
    Henry RA; Morales A; Cahill CM
    Urology; 2015 May; 85(5):1025-1033. PubMed ID: 25917728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.
    Parsons CL
    Urology; 2005 Jan; 65(1):45-8. PubMed ID: 15667861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome.
    Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG
    BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
    Jiang YH; Jhang JF; Lee CL; Kuo HC
    Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkalinized intravesical lidocaine to treat interstitial cystitis: absorption kinetics in normal and interstitial cystitis bladders.
    Henry RA; Patterson L; Nickel C; Morales A
    Urology; 2001 Jun; 57(6 Suppl 1):119. PubMed ID: 11378101
    [No Abstract]   [Full Text] [Related]  

  • 11. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
    Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis.
    Nomiya A; Naruse T; Niimi A; Nishimatsu H; Kume H; Igawa Y; Homma Y
    Int J Urol; 2013 Nov; 20(11):1118-22. PubMed ID: 23432185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic changes during therapeutic intravesical instillations of capsaicin.
    Chandiramani VA; Peterson T; Duthie GS; Fowler CJ
    Br J Urol; 1996 Jun; 77(6):792-7. PubMed ID: 8705210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients.
    Tamam Y; Özdemir HH; Gedik A; Tamam C; Nazlıkul H
    Neurourol Urodyn; 2017 Sep; 36(7):1832-1838. PubMed ID: 28084625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device.
    Nickel JC; Jain P; Shore N; Anderson J; Giesing D; Lee H; Kim G; Daniel K; White S; Larrivee-Elkins C; Lekstrom-Himes J; Cima M
    Sci Transl Med; 2012 Jul; 4(143):143ra100. PubMed ID: 22814850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
    Kuo HC
    Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin.
    Welk BK; Teichman JM
    Urology; 2008 Jan; 71(1):67-70. PubMed ID: 18242367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.